Preoperative Stereotactic Radiosurgery (SRS) vs. Postoperative SRS
Brain metastasis is one of the most common neurologic complications of cancer. Dr. Tom will discuss the role of surgery in brain metastasis, as well as provide participants with an understanding of the role of adjunctive whole-brain radiotherapy for resected brain metastasis.
Neurosurgeons, medical physicists, radiation oncologists and neuro-otolaryngologists.
- Discuss the epidemiology of brain metastasis.
- Assess the role of surgery in brain metastasis.
- Summarize the role of adjunctive whole-brain radiotherapy (WBRT) for resected brain metastasis.
- Compare the pros and cons of postoperative stereotactic radiosurgery (SRS).
- Compare the pros and cons of preoperative SRS for resected brain metastasis.
Baptist Health gratefully acknowledges the commercial support provided by Elekta for this activity.
Martin C. Tom, M.D.
Miami Cancer Institute
Baptist Health South Florida
Martin C. Tom, M.D., faculty for this educational event, receives grant/research support from Blue Earth Diagnostics. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Michael McDermott, M.D., conference director for this educational event, is a consultant with Deinde Medical and Stryker, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Rupesh Kotecha, M.D., conference director for this educational event, has received honoraria from Elekta AB, Accuray Inc., Viewray Inc., Novocure Inc., and Elsevier. He has received research support from Medtronic, B. Earth Diagnostics, Novocure, Exelixis, CT Medical, Astrazeneca and Viewray. He is also on the speakers’ bureau with Novocure and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 AMA PRA Category 1 Credit™
- 0.75 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.